MACI KELLEY: Open Payments
NPI 1942962519 · GREENEVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,175 in 85 payments from 18 companies in 2025. Trend: 2023 $365 · 2024 $1,069 · 2025 $1,175
Food & beverage: $1,175
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $332 |
| Otsuka America Pharmaceutical, Inc. | 9 | $187 |
| Novo Nordisk Inc | 11 | $178 |
| GlaxoSmithKline, LLC. | 3 | $70 |
| Exact Sciences Corporation | 4 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $43 |
| PFIZER INC. | 2 | $36 |
| Lundbeck LLC | 2 | $34 |
| Amgen Inc. | 2 | $31 |
Products named: REXULTI, VRAYLAR, UBRELVY, Ozempic, QULIPTA, TRELEGY ELLIPTA, The Cologuard Plus Collection Kit, CAPLYTA.
Industry payments across TN — which companies pay providers there.
